Evaluating the therapeutic effect of lenvatinib against advanced hepatocellular carcinoma by measuring blood flow changes using contrast‐enhanced ultrasound

BACKGROUND: The antitumor effect of a drug is considered to be associated with a decrease in tumor blood flow. AIMS: We investigated whether the efficacy of lenvatinib (LEN) could be accurately assessed by measuring blood flow in hepatocellular carcinoma (HCC) during early treatment stages. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamachi, Naoki, Nakano, Masahito, Okamura, Shusuke, Niizeki, Takashi, Iwamoto, Hideki, Shimose, Shigeo, Shirono, Tomotake, Noda, Yu, Kuromatsu, Ryoko, Koga, Hironori, Torimura, Takuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842703/
https://www.ncbi.nlm.nih.gov/pubmed/34105904
http://dx.doi.org/10.1002/cnr2.1471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842703/
https://www.ncbi.nlm.nih.gov/pubmed/34105904
http://dx.doi.org/10.1002/cnr2.1471

Ejemplares similares